Hologic helps women around the world live healthier lives. We develop innovative medical technologies that effectively detect, diagnose and treat health conditions and raise the standard of care globally.

Hologic empowers people to live healthier lives everywhere, every day. Learn about our groundbreaking technology & mission to promote women's health worldwide.

Hologic is a global, innovative medical technology company whose purpose is to enable healthier lives everywhere, every day. We are a champion of women’s health and have clear industry-leading products in each of the categories we operate: medical diagnostics, medical imaging systems and surgical devices, with more diverse revenue and growth ...

2024年2月1日 · MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX) announced today that its new Genius™ Digital Diagnostics System with the Genius™ Cervical AI algorithm has received clearance from the U.S. Food and Drug Administration (FDA), making it the first and only FDA-cleared digital cytology system that combines deep-learning-based ...

Learn how to get support for Hologic products. Find contact information, technical and applications support, ordering support, product manuals & documents.

2025年1月6日 · Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, has completed its previously announced acquisition of Gynesonics, Inc. (Gynesonics®), a privately held medical device company focused on the development of minimally invasive solutions for women’s health, for approximately $350 million.

2024年10月14日 · Hologic, Inc. (Nasdaq: HOLX), a global champion of women’s health, today announced that it has signed a definitive agreement to acquire Gynesonics, Inc. (Gynesonics®), a privately held medical device company focused on the development of minimally invasive solutions for women’s health for approximately $350 million, subject to working ...

2023年7月25日 · Learn about Hologic's innovative medical imaging solutions designed to improve breast & skeletal health, gynecological & sexual health, and body composition.

2025年2月5日 · MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX) announced today the Company’s financial results for the fiscal first quarter ended December 28, 2024 . “Our financial results for the first quarter of 2025 were consistent with our guidance overall,” said Stephen P. MacMillan, the Company’s Chairman, President and Chief ...

2024年11月4日 · MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX) announced today the Company’s financial results for the fiscal fourth quarter ended September 28, 2024 . "We delivered strong fiscal 2024 results, reinforcing our track record of durable performance with another solid quarter of growth," said Steve MacMillan, Hologic’s ...